Biotech · Private company
Attralus, Inc.
Track this companyFree. Adds Attralus, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials73 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- 124I-AT-01Phase 2 · AmyloidosisClinicalTrials.gov · fetched Nov 12, 2026
- AT02Phase 2 · Amyloidosis; SystemicClinicalTrials.gov · fetched Nov 12, 2026
- 124I-AT03Phase 1 · Amyloidosis; SystemicClinicalTrials.gov · fetched Nov 12, 2026
- AT-02Phase 1 · Amyloidosis; SystemicClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- 124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel SyndromePHASE2 · ENROLLING_BY_INVITATION · started May 22, 2025ClinicalTrials.gov NCT06907849 · fetched Nov 12, 2026
- A Study of AT-02 in Subjects With Systemic Amyloidosis.PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 21, 2023ClinicalTrials.gov NCT05951049 · fetched Nov 12, 2026
- Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic AmyloidosisPHASE2 · RECRUITING · started Jan 10, 2023ClinicalTrials.gov NCT05758493 · fetched Nov 12, 2026
- Study of AT-02 in Healthy Volunteers and Subjects With Systemic AmyloidosisPHASE1 · UNKNOWN · started Sep 1, 2022ClinicalTrials.gov NCT05521022 · fetched Nov 12, 2026
- Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTRPHASE2 · COMPLETED · started Jul 8, 2022ClinicalTrials.gov NCT05635045 · fetched Nov 12, 2026
- A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic AmyloidosisPHASE2 · COMPLETED · started Nov 30, 2021ClinicalTrials.gov NCT05235269 · fetched Nov 12, 2026
- A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic AmyloidosisPHASE1 · COMPLETED · started Nov 30, 2021ClinicalTrials.gov NCT05201911 · fetched Nov 12, 2026